Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.884 EUR | -2.89% | -5.33% | -47.00% |
Apr. 04 | AB Science's Reconsideration Request for ALS Treatment Granted Eligibility in Canada | MT |
Apr. 03 | AB Science: reconsideration possible for masitinib in ALS | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-47.00% | 106M | |
+4.16% | 70.78B | |
+10.51% | 9.15B | |
-17.03% | 4.84B | |
+37.51% | 4.22B | |
+3.92% | 3.92B | |
+18.14% | 2.55B | |
-24.13% | 2.26B | |
-29.70% | 2.24B | |
+9.09% | 1.92B |
- Stock Market
- Equities
- AB Stock
- News AB Science
- AB Science : To Resume Patient Enrollment In Late-Stage Study Of Sclerosis Drug